Levels of α1 acid glycoprotein and ceruloplasmin predict future albumin levels in hemodialysis patients

Kidney International

Volumn 60, Issue 6, 2001, Pages 2360-2366

  Kaysen, George A ^a,b,c   Dubin, Joel A ^a,b,c   Müller, Hans G ^a,b,c   Mitch, William E ^a,b,c   Levin, Nathan W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RENAL RESEARCH INSTITUTE   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^e YALE UNIVERSITY   (United States)

Author keywords

Acute phase proteins; C reactive protein; Hemodialysis; Hypoalbuminemia; Inflammation

Indexed keywords

CERULOPLASMIN; OROSOMUCOID; SERUM ALBUMIN; ALBUMIN; C REACTIVE PROTEIN; TRANSFERRIN;

ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; FEMALE; FORECASTING; HEMODIALYSIS; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; OSMOLARITY; ALBUMIN BLOOD LEVEL; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; INFLAMMATION; MAJOR CLINICAL STUDY; MEASUREMENT; MODEL; PREDICTION; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ADULT; AGED; AGED, 80 AND OVER; CERULOPLASMIN; FEMALE; FORECASTING; HUMAN; LONGITUDINAL STUDIES; MALE; MIDDLE AGE; MODELS, BIOLOGICAL; OROSOMUCOID; OSMOLAR CONCENTRATION; RENAL DIALYSIS; SERUM ALBUMIN; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034747064     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.00052.x     Document Type: Article

References (38)

1. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
2. Race and diabetes as death risk predictors in hemodialysis patients
3. Malnutrition in hemodialysis patients
4. C-reactive4, 2000, C-reactive protein supercedes albumin in predicting mortality in hemodialysis patients
5. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
6. Renal replacement therapy in the United States: Data from the United States renal data system
7. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
8. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
9. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
10. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
11. C-reactive protein and outcome after ischemic stroke
12. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
13. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
14. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
15. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease
16. 125I-labelled human alpha 1-acid glycoprotein
17. Turnover of iodine-131-labelled ceruloplasmin in human beings
18. Random-effects models for longitudinal data
19. A new look at statistical model identification
20. Effect of dietary protein intake on albumin homeostasis in nephrotic patients
21. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis
22. Mechanisms of hypoalbuminemia in hemodialysis patients
23. Albumin metabolism in the nephrotic syndrome in adults
24. Elevation of albumin synthesis rates in nephrotic patients measured with [1-13C] leucine
25. Regulation of albumin synthesis and catabolism by alteration of dietary protein
26. The effect of dietary protein deficiency on albumin synthesis and on the concentration of active albumin messenger ribonucleic acid in rat liver
27. Effect of a short term fast on the distribution of cytoplasmic albumin messenger ribonucleic acid in rat liver
28. Identification of albumin mRNP’s in the cytosol of fasting rat liver and influence of tryptophan or a mixture of amino acids
29. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
30. Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation
31. A simple bioassay for monocyte-derived hepatocyte stimulating factor: Increased synthesis of α2-macroglobulin and reduced synthesis of albumin by cultured rat hepatocytes
32. Determinants of albumin concentration in hemodialysis patients
33. Albumin synthesis
34. Albumin synthesis
35. Hemodialysis and the acute-phase response in chronic uremic patients
36. 1 acid glycoprotein gene transcription
37. Synthesis rate of plasma albumin is a good indicator of liver albumin synthesis in sepsis